Can people with cystic fibrosis have children and what are the risks? 

People with cystic fibrosis can become biological parents, though the process often requires medical assistance and careful health planning. Significant advancements in assisted reproductive technology and improved long-term health management have made parenthood a realistic goal for many individuals with the condition in the United Kingdom. However, starting a family involves navigating specific fertility challenges, understanding the genetic risks for the child, and ensuring the health of the parent is stable enough to manage the physical demands of pregnancy or early parenthood. 

What We’ll Discuss in This Article 

• The biological impact of cystic fibrosis on male and female fertility. 

• Genetic inheritance patterns and the risk of passing on the condition. 

• The role of carrier testing for partners. 

• Assisted reproductive options such as IVF and ICSI. 

• Risks and health considerations for women during pregnancy. 

• The importance of genetic counselling and specialist clinical support. 

Fertility challenges in men and women 

The primary obstacle to natural conception in men with cystic fibrosis is a structural issue present from birth. Approximately 98% of men with the condition have congenital bilateral absence of the vas deferens (CBAVD), meaning the tubes that transport sperm from the testicles are missing or blocked. The NHS confirms that while these men produce healthy sperm, the blockage prevents it from being ejaculated, leading to infertility that usually requires surgical sperm retrieval to achieve pregnancy. 

For women, fertility is generally preserved, though it can be more difficult to conceive naturally compared to those without the condition. Thickened cervical mucus, a hallmark of cystic fibrosis, can act as a physical barrier to sperm, making it harder for it to reach the egg. Additionally, NICE guidance notes that factors such as low body weight, poor nutrition, and frequent lung infections can cause irregular menstrual cycles or delayed ovulation, further impacting fertility. Despite these challenges, many women can conceive naturally when their health is well-managed. 

Understanding the genetic risks for the child 

Cystic fibrosis is an autosomal recessive condition, meaning a child must inherit two faulty copies of the CFTR gene one from each parent to have the condition. If one parent has cystic fibrosis, they will definitely pass one faulty gene to their child. The overall risk to the baby depends entirely on whether the other parent is a carrier of the cystic fibrosis gene. 

In the United Kingdom, approximately 1 in 25 people are healthy carriers of a faulty cystic fibrosis gene. According to the NHS, if a person with cystic fibrosis has a child with a partner who is a carrier, there is a 50% chance the baby will have the condition and a 50% chance they will be a carrier. If the partner is not a carrier, the child will be a carrier but will not have cystic fibrosis themselves. Genetic testing for the partner is essential for any couple planning a pregnancy to understand these probabilities. 

Options for assisted reproduction 

Because natural conception is often difficult or impossible, many couples utilise assisted reproductive technologies available through specialist fertility clinics in the UK. 

• Sperm Retrieval (MESA/TESE): A minor surgical procedure used for men with CBAVD to collect sperm directly from the testicles or epididymis. 

• Intracytoplasmic Sperm Injection (ICSI): A single retrieved sperm is injected directly into an egg as part of an IVF cycle. 

• In Vitro Fertilisation (IVF): Used to assist women with thick cervical mucus or to facilitate genetic screening of embryos. 

• Pre-implantation Genetic Testing (PGT-M): This allows embryos created via IVF to be tested for cystic fibrosis before they are implanted in the womb, ensuring the child will not inherit the condition. 

Risks and health considerations for pregnancy 

Pregnancy places significant physical demands on the body, which can be particularly challenging for women with cystic fibrosis. The primary risks involve a potential decline in lung function and difficulty maintaining the increased caloric intake required for a healthy pregnancy. NICE clinical standards recommend that women should have a stable lung function (typically an FEV1 above 50%) and a healthy nutritional status before considering pregnancy to minimise these risks. 

Close monitoring by a multidisciplinary team, including obstetricians and cystic fibrosis specialists, is vital throughout the pregnancy. The team will monitor for complications such as gestational diabetes or worsening respiratory infections. While most medications used to treat cystic fibrosis are safe during pregnancy, the specialist team will review all prescriptions to ensure the best balance between maternal health and foetal safety. 

Factor	Impact on Parenthood	Common Solution
Male Infertility	Blocked vas deferens (CBAVD).	Sperm retrieval and ICSI.
Female Fertility	Thickened cervical mucus.	Nutritional optimisation or IVF.
Genetic Risk	50% risk if partner is a carrier.	Partner carrier testing and PGT-M.
Pregnancy Risk	Potential decline in lung function.	Pre-conception health optimisation.

Conclusion 

People with cystic fibrosis can successfully have children, but the process involves careful genetic screening and often medical assistance to overcome fertility barriers. The primary risks involve the genetic probability of the child inheriting the condition and the physical impact of pregnancy on the mother’s respiratory health. With the support of specialist NHS clinics and modern fertility treatments, many individuals can safely navigate these challenges to start a family. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article provides a medically accurate overview of fertility and the risks of parenthood for people with cystic fibrosis, strictly following the clinical guidelines of the NHS and NICE. The content is authored by a medical content team and has been reviewed by Dr. Rebecca Fernandez, a UK-trained physician with experience in internal medicine, cardiology, and emergency care. It is intended to offer evidence-based guidance for patients and families considering reproductive options within the UK healthcare system.